Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Century Therapeutics (IPSC) Intangibles (2024 - 2025)

Century Therapeutics (IPSC) has disclosed Intangibles for 2 consecutive years, with $34.2 million as the latest value for Q4 2025.

  • Quarterly Intangibles changed 0.0% to $34.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $34.2 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $34.2 million for FY2025, 0.0% changed from the prior year.
  • Intangibles for Q4 2025 was $34.2 million at Century Therapeutics, roughly flat from $34.2 million in the prior quarter.
  • The five-year high for Intangibles was $34.2 million in Q4 2024, with the low at $33.3 million in Q2 2024.